Table 2.
Summary of experimental results in this study.
| Dog number |
Dog weight (kg) |
Prostate size (ml) |
Injected dose (ml/lobe) |
Injection site |
Visualized lymph node chains | Visibility window (minutes) |
Periprostatic leak |
|---|---|---|---|---|---|---|---|
| 1 | 41.3 | 25 | 2.5 | Left | R common iliac, retroperitoneal | 0-30 | Large |
| 2 | 28 | 21 | 2 | Right | 1 common iliac, retroperitoneum | 0-30 | Large |
| 3 | 25.7 | 27 | 0.5 | Left | L internal iliac, bilateral common iliac |
0-21 | Moderate |
| 3 | 25.7 | 27 | 0.5 | Right | Bilateralcommon iliac | 0-30 | Moderate |
| 1 | 38.6 | 25 | 0.2 | Right | R common iliac, retroperitoneal | 0-30 | Small |
| 2 | 29.1 | 21 | 0.2 | Right | R common iliac, retroperitoneum | 0-30 | Small |
| 3 | 26.5 | 27 | 0.2 | Left | L internal iliac, L common iliac | 7-30 | Small |
| 1 | 39 | 25 | 0.1 | Right | R common iliac, retroperitoneum | 0-21 | Minimal |
| 1 | 39 | 25 | 0.1 | Left | Lcommon iliac | 0-14 | Minimal |
| 3 | 26.5 | 27 | 0.1 | Right | R common iiiac | 0-7 | none |